Skip to content
Skip to main navigation
VHIO - Vall d'Hebron Institute of Oncology
Vall d'Hebron
CONTACT
RSS
WEB MAP
Català
Castellano
English
18/05/12
Search
Search
Research Team
Research Programs
About VHIO
News
Press Kit
Home
>
Research Programs
> Clinical trials
Estudio fase II de dasatinib (BMS-354825) en cáncer de mama avanzado fenotipo “triple negativo”)
Code: CA180-059
<< Previous
1
Next>>